Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Mallinckrodt
Johnson and Johnson
McKinsey
Harvard Business School

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Amonafide

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Amonafide?

Amonafide is an investigational drug.

There have been 5 clinical trials for Amonafide. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2007.

The most common disease conditions in clinical trials are Leukemia, Myeloid, Leukemia, and Leukemia, Myeloid, Acute. The leading clinical trial sponsors are Antisoma Research, Xanthus Pharmaceuticals, Inc., and Memorial Sloan Kettering Cancer Center.

Recent Clinical Trials for Amonafide
TitleSponsorPhase
A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML)Antisoma ResearchPhase 2
Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE StudyAntisoma ResearchPhase 3
Amonafide in Combination With Cytarabine in Secondary AMLXanthus Pharmaceuticals, Inc.Phase 2

See all Amonafide clinical trials

Clinical Trial Summary for Amonafide

Top disease conditions for Amonafide
Top clinical trial sponsors for Amonafide

See all Amonafide clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Boehringer Ingelheim
Colorcon
Express Scripts
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.